Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-37.4%
5Y CAGR-42.2%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-37.4%/yr
vs +3.0%/yr prior
5Y CAGR
-42.2%/yr
Recent acceleration
Acceleration
-40.5pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.51 | +7.5% |
| 2024 | 3.26 | -73.7% |
| 2023 | 12.41 | -13.3% |
| 2022 | 14.32 | -55.2% |
| 2021 | 31.92 | -41.2% |
| 2020 | 54.31 | +529.7% |
| 2019 | 8.63 | -32.1% |
| 2018 | 12.70 | +325.5% |
| 2017 | 2.98 | -20.1% |
| 2016 | 3.73 | - |